Marker Therapeutics (MRKR) FCF Margin (2017 - 2025)
Marker Therapeutics (MRKR) recorded FCF Margin of -172.20% in Q4 2025, up 36.67 percentage points from -208.86% a year earlier and up 49.70 percentage points from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) FCF Margin (2017 - 2025) Analysis & Trends
For FY2025, Marker Therapeutics reported FCF Margin of -338.74%, down 173.21 percentage points from FY2024.
- Annual FCF Margin has a five-year change of +5026.02 percentage points (FY2020 to FY2025).
- Across earlier years, FCF Margin came in at -165.53% in FY2024 (+330.97 pp), -496.51% in FY2023 (+271.16 pp), -767.66% in FY2022 (+1429.29 pp) and -2196.95% in FY2021 (+3167.81 pp).
- The Q4 2025 figure is the highest quarterly FCF Margin since Q3 2024.
- On a year-over-year basis, FCF Margin rose in four of the last seven quarters, with an average year-over-year change of -140.74 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 1032.31 percentage points in Q1 2023, against a drop of 1266.95 percentage points in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -221.90% (Q3 2025), -218.11% (Q2 2025) and -1575.39% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 2.01% |
| 10 | Marker Therapeutics | 20.86 Mn | -39.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -172.20% |
| Sep 30, 2025 | -221.90% |
| Jun 30, 2025 | -218.11% |
| Mar 31, 2025 | -1,575.39% |
| Dec 31, 2024 | -208.86% |
| Sep 30, 2024 | 62.17% |
| Jun 30, 2024 | -305.12% |
| Mar 31, 2024 | -308.43% |
| Dec 31, 2023 | -224.09% |
| Sep 30, 2023 | -437.67% |
| Dec 31, 2022 | -847.37% |
| Sep 30, 2022 | -774.87% |
| Jun 30, 2022 | -387.21% |
| Mar 31, 2022 | -1,522.13% |
| Dec 31, 2020 | -28,915.72% |
| Jun 30, 2020 | -1,741.89% |
| Dec 31, 2019 | -2,145.33% |
| Jun 30, 2018 | -1,164.70% |
| Sep 30, 2017 | -1,106.36% |
API Access
Marker Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();